facebook twitter linkedin

This material was prepared by a third party towards Selvita S.A. with its registered office in Kraków (hereunder: “Selvita”). Within the scope which was not authorized by Selvita’s management board, the description of factual circumstances regarding the activities of Selvita, embodied in this material presents merely opinion of the third party, in particular with respect to presented opinions, predictions, appraisals and forecasts of the financial data and future activity of Selvita and its results.

Therefore, Selvita does not warrant consistency of this material with the actual and legal situation. Neither Selvita, members of its corporate bodies, employees nor its consultants shall bear any liability for validity of opinions, predictions, appraisals, forecasts and any other date embodied in this material as well as for consequences of actions of any reader made on a basis of this material, in particular for the investment decisions or any losses resulting from use of this material.

Readers of this material shall make its own assessment, whether opinions or forecasts embodied therein are credible and adequate, in particular taking into account their investment strategy and actual and legal situation. In particular they should consult it with their independent financial and investment advisors. None of the information presented in this material shall constitute investment, legal, accounting or tax advice or a statement that any investment strategy is accurate or adequate, considering the circumstances of the reader.

Furthermore date presented in this material shall not constitute an offer to sell or purchase any financial instruments nor an invite the make such offer. It shall not be also not deemed as a recommendation for investment in any financial instrument nor an advertisement of such instruments.



DISAGREE AGREE

About the biotechnology industry

 
Best and worst 2014 biotech performers on Wall Street Źródło: FierceBiotech
 
Biopharma posts a chart-topping 41 new drug approvals in 2014 - Źródło: FierceBiotech
 
Ernst & Young Biotechnology Industry Report 2014- Beyond Borders. Unlocking value. - Source: Ernst & Young
 
The top 5 trends for biotech in 2015 - Source: FierceBiotech
 
MoFo Biometer. Biotechnology health index - Source: Morrison Foerster

MoFo Biometer October 2014 - Source: Morrison Foerster
 
Inside Innovation: The Drug Discovery Process - Source: innovation.org
 
Drug Discovery and Development. Understanding the R&D process - Source: innovation.org